Prism Medico — 360° view

Prism Medico, a company in the Non Banking Financial Company (NBFC) industry, reported revenue of ₹0.18 crore and net profit of ₹0.23 crore for the September 2026 quarter.

Prism Medico (BSE: PRISMMEDI) closed at ₹34.80 on 20 Nov 2026, up 83.9% over the past year. Its market capitalisation is ₹47 crore.

Share price
₹34.80 (20 Nov 2026)
Market cap
₹47 Cr (20 Nov 2026)
Revenue
₹0 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
2.82% (FY26)
ROE
2.10% (FY26)
Book value
₹24.4 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹37.88 / ₹15.51 (20 Nov 2026)
1-year return
83.9% (to 20 Nov 2026)
Sector
Financial Services
Industry
Non Banking Financial Company (NBFC)
Symbol
BSE: PRISMMEDI

Incorporated in 1985, Prism Medico & Pharmacy Ltd manufactures, trades, and distributes chemicals, medicines, pharmaceuticals, cosmetics, and related products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.